journal cover

Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma

Annals of Surgery

May 21, 2010

Nigel Balfour JamiesonRoss Carter

Download from

Publisher
PubMed

Abstract

To determine the prognostic influence of residual tumor at or within 1 mm of the mobilization margins (R1Mobilization) compared with transection margins (R1Transection) following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma (PDAC). The prognostic strength of R1 status in...read more

Mentioned in this Paper

Immunologic Adjuvants
Pancreatic Ductal Adenocarcinoma
Adjuvant
Pancreatitis
Blood Vessel
Pancreaticoduodenectomy
Malignant Neoplasm of Pancreas
Carcinoma, Cribriform
Neoplasm, Residual
Carcinoma, Pancreatic Ductal
Paper Details
References
  • References33
  • Citations78
1234
  • References33
  • Citations78
12345...

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

© 2020 Meta ULC. All rights reserved

Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma

Annals of Surgery

May 21, 2010

Nigel Balfour JamiesonRoss Carter

PMID: 20485150

DOI: 10.1097/sla.0b013e3181d77369

Abstract

To determine the prognostic influence of residual tumor at or within 1 mm of the mobilization margins (R1Mobilization) compared with transection margins (R1Transection) following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma (PDAC). The prognostic strength of R1 status in...read more

Mentioned in this Paper

Immunologic Adjuvants
Pancreatic Ductal Adenocarcinoma
Adjuvant
Pancreatitis
Blood Vessel
Pancreaticoduodenectomy
Malignant Neoplasm of Pancreas
Carcinoma, Cribriform
Neoplasm, Residual
Carcinoma, Pancreatic Ductal

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

The British Journal of Surgery

Redefining the R1 resection in pancreatic cancer(opens in new tab)

The British Journal of SurgeryJune 29, 2006
C S VerbekeA Anthoney
Paper Details
References
  • References33
  • Citations78
1234
  • References33
  • Citations78
12345...

Download from

Publisher
PubMed
/papers/positive-mobilization-margins-alone-do-not/20485150